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Introduction
Chronic vascular disorders, such as atherosclerosis and pulmo-
nary  arterial  hypertension  (PAH;  Humbert  et  al.,  2004),  are 
characterized  by  expansion  of  dedifferentiated  cells  bearing 
vascular smooth muscle cell (SMC [VSMC]) markers within 
the neointima and media of the vessel wall. The functional   
impact of this abnormality is that it increases resistance to blood 
flow and produces tissue ischemia (Raines and Ross, 1993;   
Willis et al., 2004). It has been proposed that, in response to 
vascular injury, proteolysis and subsequent alterations in the 
composition of the extracellular matrix induce the release and 
activation of mitogenic and motogenic factors that cause expan-
sion, dedifferentiation, and migration of VSMCs (Chait, 1987; 
Voelkel and Tuder, 1997). For example, in the pulmonary circu-
lation, endothelial injury can induce an elastolytic enzyme that 
both mediates release of growth factors (Goodall et al., 2001; 
Thompson and Rabinovitch, 1996) and enhances the potency of 
their biological effects by inducing tenascin-C–mediated acti-
vation of their receptors (Jones et al., 1997). Our recent studies 
have shown that signaling through the bone morphogenetic pro-
tein (BMP) receptor II (BMPRII) can both facilitate pulmo-
nary artery (PA) SMC motility (Spiekerkoetter et al., 2009) and   
suppress proliferation in response to growth factors such as 
W
e present a novel cell-signaling paradigm in 
which bone morphogenetic protein 2 (BMP-2) 
consecutively  and  interdependently  activates 
the wingless (Wnt)–-catenin (C) and Wnt–planar cell 
polarity  (PCP)  signaling  pathways  to  facilitate  vascular 
smooth muscle motility while simultaneously suppressing 
growth. We show that BMP-2, in a phospho-Akt–dependent 
manner, induces C transcriptional activity to produce   
fibronectin, which then activates integrin-linked kinase 1 
(ILK-1) via 4-integrins. ILK-1 then induces the Wnt–PCP 
pathway by binding a proline-rich motif in disheveled (Dvl) 
and consequently activating RhoA-Rac1–mediated motility. 
Transfection of a Dvl mutant that binds C without activat-
ing RhoA-Rac1 not only prevents BMP-2–mediated vascu-
lar smooth muscle cell motility but promotes proliferation 
in association with persistent C activity. Interfering with 
the Dvl-dependent Wnt–PCP activation in a murine stented 
aortic  graft  injury  model  promotes  extensive  neointima   
formation,  as  shown  by  optical  coherence  tomography 
and histopathology. We speculate that, in response to in-
jury, factors that subvert BMP-2–mediated tandem activa-
tion  of  Wnt–C  and  Wnt–PCP  pathways  contribute  to 
obliterative vascular disease in both the systemic and pul-
monary circulations.
BMP promotes motility and represses growth of 
smooth muscle cells by activation of tandem  
Wnt pathways
Vinicio A. de Jesus Perez,
1 Ziad Ali,
1 Tero-Pekka Alastalo,
2 Fumiaki Ikeno,
1 Hirofumi Sawada,
2 Ying-Ju Lai,
2  
Thomas Kleisli,
2 Edda Spiekerkoetter,
1 Xiumei Qu,
1 Laura H. Rubinos,
4 Euan Ashley,
1 Manuel Amieva,
2  
Shoukat Dedhar,
3 and Marlene Rabinovitch
2
1Department of Medicine and 
2Department of Pediatrics, Stanford University, Stanford, CA 94305
3Department of Biochemistry and Molecular Biology, University of British Columbia, Vancouver, British Columbia V6T 1Z3, Canada
4Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030
© 2011 de Jesus Perez et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub-
lication date (see http://www.rupress.org/terms). After six months it is available under a 
Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, 
as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
I
O
L
O
G
YJCB • VOLUME 192 • NUMBER 1 • 2011   172
PDGF-BB (Hansmann et al., 2008). In addition, other inves-
tigators have demonstrated that BMPRII ligands can reduce 
neointima formation in response to systemic vascular insults 
(Nakaoka et al., 1997).
Based on the aforementioned studies, it follows that neo-
intima formation might occur in response to vascular damage in 
patients with dysfunctional BMPRII signaling. Although muta-
tions in BMPRII are identified in 70% of patients with familial 
idiopathic PAH (IPAH) and 25% of those with sporadic IPAH, 
reduced  BMPRII  expression  is  noted  in  all  forms  of  PAH 
(Machado et al., 2001; Humbert et al., 2004). Consistent with 
this, PASMCs isolated from IPAH patients carrying BMPRII 
mutations exhibit resistance to apoptosis and enhanced prolifer-
ation in response to growth factors (Morrell et al., 2001; Zhang 
et al., 2003).
In contrast to its role in the inhibition of proliferation, we 
recently showed that BMPRII-mediated signaling is necessary 
for PASMC motility (Spiekerkoetter et al., 2009). In human (h) 
PA endothelial cells (PAECs), BMPRII signals mediate motility 
by  recruiting  the  noncanonical  wingless  (Wnt)–planar  cell   
polarity (PCP) pathway via phospho (p) Smad interaction with 
disheveled (Dvl; de Jesus Perez et al., 2009). We therefore   
hypothesized that, in VSMCs, BMPRII-mediated signals might 
activate the Wnt–PCP pathway to facilitate cell motility while 
suppressing concurrent activation of the Wnt–-catenin (C) 
signaling pathway, which was shown to be pro-proliferative in 
hPAECs (de Jesus Perez et al., 2009).
Our results indicate that a novel tandem and interdepen-
dent activation of Wnt–C and Wnt–PCP signaling is required 
for BMP-mediated VSMC motility. We show that BMP-2, via 
pAkt, inactivates GSK3, causing transient accumulation and 
transcriptional activity of C, which is required to increase pro-
duction and secretion of fibronectin (FN). We show that FN   
interacts with 4-integrins to activate integrin-linked kinase 1 
(ILK-1). This leads to the formation of a complex between   
ILK-1 and Dvl, which is necessary to both activate RhoA-Rac1– 
mediated VSMC motility and repress C accumulation and VSMC 
proliferation.  Using  a  murine  aortic  graft  stent  as  an  injury 
model, we show that transfection of a dominant-negative Dvl 
construct that causes persistent Wnt–C activity without tan-
dem recruitment of Wnt–PCP enhances neointima formation.
Results
BMP-2 stimulates PASMC migration via 
BMPRII-dependent activation of RhoA  
and Rac1
Previously,  our  group  demonstrated  that  BMP-2  stimulates 
hPAEC motility via the Wnt–PCP pathway (de Jesus Perez   
et al., 2009). To investigate whether this mechanism was also 
involved in the regulation of motility in hPASMCs, we used a 
Boyden chamber assay. We demonstrated that 10 ng/ml BMP-2 
increased hPASMC motility in a manner comparable with that 
observed with 20 ng/ml PDGF-BB, the positive control (Fig. 1 A). 
Next, we documented activation of the small GTPases RhoA 
and Rac1 (Fig. 1 B) using whole cell lysates harvested up to   
6 h after stimulation with BMP-2. Active forms of RhoA and 
Figure 1.  BMP-2–mediated migration of hPASMCs requires activation of 
RhoA and Rac1. (A) Migration was assessed using the Boyden chamber 
assay as described in Materials and methods. Cells were starved for 48 h 
in starvation media (0.1% FBS) before seeding them in Boyden chambers 
placed in 24-well plates containing either starvation media alone or sup-
plemented with 10 ng/ml BMP-2 or 20 ng/ml PDGF-BB. (B) RhoA (top) and 
Rac1 (bottom) activation was measured in lysates from cells stimulated with 
BMP-2 over a period of 6 h using the approach described in Materials and 
methods. Densitometry values are shown relative to total RhoA and Rac1 
in whole cell lysates that were run in different gels. (C) Motility response to 
BMP-2 was assessed in cells incubated with either Y-27632 at 10, 50, and 
100 mM or DMSO for 6 h. Bars represent means ± SEM from n = 3 dif-
ferent cell harvests in triplicate. ***, P < 0.0001 versus control or time 0; 
and 
##, P < 0.001 versus uninhibited control using one-way ANOVA with 
the Dunnett (A and B) or Bonferroni (C) tests. CON, control.173 BMP-2 recruits Wnt pathways in smooth muscle cells • de Jesus Perez et al.
(Ding et al., 2000; Logan and Nusse, 2004; Ng et al., 2009). 
Several kinases have been shown to participate in inducing C 
accumulation by disrupting the C–Axin–GSK3 degradation 
complex (Ding et al., 2005; Thornton et al., 2008). We have 
shown in PAECs that BMP-2 increases C levels and transcrip-
tional activity via p-extracellular signal related kinase (ERK)–
mediated  disruption  of  the  C–Axin–GSK3  degradation 
complex (de Jesus Perez et al., 2009). Based on this observa-
tion, we proposed that kinase-dependent disruption of the   
C–Axin–GSK3 degradation complex was required for the 
BMP-2–mediated increase in C. To test this, we determined 
whether C accumulation could be temporally related to the 
phosphorylation state of kinases known to be activated by BMP 
stimulation, such as pERK, p-p38, and pAkt, in the setting of 
reduced BMPRII levels. We found that after 1 h of BMP-2 stim-
ulation, activation of ERK and p38 but not Akt was evident in 
BMPRII-deficient hPASMCs (unpublished data). Furthermore, 
lack of Akt activation also associated with loss of GSK3  
Ser 21 phosphorylation and C accumulation. This led us   
to propose that pAkt could be regulating the stability of the 
C–Axin–GSK3 degradation complex in hPASMCs.
To fully confirm the critical role of pAkt in regulating C 
levels in hPASMCs, we transfected cells with either a vector   
or a dominant-negative () Akt construct (see Materials and   
methods). Consistent with our previous observations, we found 
that BMP-2 stimulation failed to induce C accumulation and 
GSK3 Ser 21 phosphorylation in Akt-transfected hPASMCs 
after 1 h (Fig. 3 A). Similar results were obtained when BMP-2 
stimulation was repeated using hPASMC-incubated cells with 
10 nM wortmannin, an inhibitor of Akt activation (García et al., 
2009), for 1 h before addition of BMP-2. This abrogated phos-
phorylation of both Akt and GSK3 as well as C accumula-
tion (Fig. S2 A) and its transcriptional activity (Fig. S2 B), 
further supporting the requirement of Akt activation for BMP-2–
mediated C accumulation.
Because the pSmads 1/5/8 are also mediators of BMPRII 
signaling (Morrell, 2006) and regulate PAEC motility (de Jesus 
Perez et al., 2009), we investigated whether they might influ-
ence C-dependent migration in hPASMCs. After transfection 
of a dominant-negative Smad 1 construct, we stimulated cells 
with BMP-2 and measured C levels in whole cell lysates.   
We found that the BMP-2–induced increase in C was not   
affected by disrupting pSmad 1 signaling (Fig. 3 B), suggesting 
that the mechanism for C accumulation under BMP-2 stimula-
tion is Smad 1/5/8 independent.
BMP-2 requires C to induce  
FN in hPASMCs
Our next goal was to identify targets of BMP-2–mediated C 
accumulation and transcriptional activity that could be related 
to hPASMC motility. FN is dependent on Wnt–C signaling 
during murine lung development (De Langhe et al., 2005) and 
has also been implicated in VSMC motility (Boudreau et al., 
1991). Our study shows that BMP-2 induced a greater than two-
fold increase in FN mRNA, peaking as early as 1 h after stimu-
lation and remaining elevated over control levels at 4 h (Fig. 4 A). 
Furthermore, an increase in secreted FN was also noted as early 
Rac1 were precipitated as described in Materials and methods. 
We found that, although BMP-2–mediated activation of Rac1 was 
observed at 1 h, an increase in active RhoA was evident only at 
6 h (Fig. 1 B). To determine whether RhoA activation is re-
quired for BMP-2–induced PASMC migration, we blocked the 
activation of Rho kinase I/II (ROCK I/II), a downstream target 
of RhoA involved in cell motility. Indeed, using Y-27632, a spe-
cific ROCK I/II inhibitor (Loirand et al., 2006), we observed a 
dose-dependent reduction in BMP-2–mediated hPASMC mi-
gration (Fig. 1 C).
We next determined whether loss of function of BMPRII, 
previously  shown  to  impair  motility  of  cultured  hPASMCs 
(Spiekerkoetter et al., 2009), does so by impeding activation of 
RhoA  and  Rac1.  Using  BMPRII  siRNA  (see  Materials  and 
methods), we confirmed reduced levels of BMPRII to <50% of 
control siRNA values 48 h after transfection, as previously re-
ported by our group (Spiekerkoetter et al., 2009). This resulted 
in loss of RhoA and Rac1 activation in response to BMP-2   
(Fig. S1 A). As expected, although BMP-2–mediated PASMC 
migration was lost in BMPRII-deficient cells, their response to 
PDGF-BB was preserved (Fig. S1 B).
BMP-2–mediated hPASMC migration 
requires the Wnt–C pathway
We recently reported that BMP-2 simultaneously recruits the 
Wnt–C pathway to induce proliferation of hPAECs and the 
Wnt–PCP pathway to stimulate migration (de Jesus Perez et al., 
2009).  Because  BMP-2  does  not  mediate  proliferation  of 
hPASMCs  (Morrell  et  al.,  2001),  we  anticipated  that  the   
Wnt–C pathway would not be activated. However, we found 
that BMP-2 induced a transient increase in C beginning at   
10 min, persisting for 4 h but falling below baseline levels at   
6 h (Fig. 2 A). To investigate whether this transient increase in 
C was required for BMP-2–mediated hPASMC migration, we 
transfected cells with two independent C-specific siRNAs at   
a concentration that resulted in a >50% reduction in protein 
(Fig. S1 C) and performed Boyden chamber assays. In the set-
ting of reduced C, we not only found that BMP-2 failed to   
activate RhoA and Rac1 (Fig. 2 B) but also could not induce 
hPASMC migration (Fig. 2 C).
To determine whether the transient increase in C after 
BMP-2 stimulation, which was required for hPASMC migration, 
was associated with C transcriptional activity, we transfected 
cells with either the topflash C reporter construct or fopflash, a 
mutated negative control (de Jesus Perez et al., 2009). A signifi-
cant increase in reporter activity was found in hPASMCs stimu-
lated with BMP-2 over a 6-h period (Fig. S1 E). Conversely, we 
confirmed that reduction of BMPRII was associated with loss   
of BMP-2–mediated C transcriptional activity (Fig. S1 D). We 
next investigated how BMP-2 via BMPRII might be increasing 
C accumulation and subsequent transcriptional activity.
BMP-2 increases C levels in hPASMCs  
via pAkt-mediated disruption of the  
Axin–GSK3–C complex
Accumulation of C levels in mammalian cells is largely de-
pendent on disruption of binding between C, Axin, and GSK3 JCB • VOLUME 192 • NUMBER 1 • 2011   174
To determine whether BMP-2 could activate ILK-1 in an FN-
dependent manner, ILK-1 kinase activity was first measured 
by  incubating  lysates  from  BMP-2–stimulated  cells  with 
GSK3, a known substrate of ILK-1, followed by measure-
ment of Ser 21 phosphorylation. BMP-2 induced significantly 
higher levels of ILK-1 activity at 1 and 4 h after stimulation 
when compared with baseline (Fig. 5 A). When cells were   
incubated with 5 µg/ml CS-1, an FN-specific peptide that inter-
acts with the 41-integrin complex and prevents its binding 
to FN, no ILK-1 activity was observed. Furthermore, coincu-
bation  with  CS-1  selectively  abrogated  BMP-2–mediated 
PASMC migration (Fig. 5 B). Because CS-1 is highly specific 
for  the  41-integrin  receptor  complex  (Waitkus-Edwards   
et al., 2002), our findings suggest that binding of FN to the 
as 1 h and remained elevated at 4 and 6 h after BMP-2 stimula-
tion (Fig. 4 B). The BMP-2–mediated increase in FN was C 
dependent, as it was lost in cells treated with two independent 
C-specific siRNAs but not control siRNA (Fig. 4 B). Immuno-
fluorescence staining of hPASMCs showed an increase in FN as 
early as 1 h after BMP-2 stimulation, which was lost when cells 
were pretreated with C siRNA (Fig. 4 C).
ILK-1 activation is required for  
BMP-2–mediated hPASMC motility
FN directs cell movement through its interaction with integ-
rin receptors located on cell surfaces (Troussard et al., 1999) and 
by  subsequent  activation  of  ILK-1  (Legate  et  al.,  2009;   
Streuli and Akhtar, 2009; Vicente-Manzanares et al., 2009).   
Figure  2.  Activation  of  C  is  required  for 
BMP-2–mediated hPASMC motility. (A) Levels   
of active C in lysates obtained from 10 ng/ml 
BMP-2–stimulated  cells  over  6  h  were  mea-
sured  by  Western  immunoblotting  (top)  and 
quantified  using  densitometry  (bottom)  ex-
pressed as the ratio of the OD of C relative 
to -tubulin. (B) RhoA (top) and Rac1 (bottom) 
activation was measured in lysates from cells 
transfected  with  either  scrambled  or  two  in-
dependent C siRNAs stimulated with BMP-2 
over a period of 6 h using the approach de-
scribed in Materials and methods. Densitom-
etry values are shown relative to total RhoA 
and Rac1 in whole cell lysates, which were 
run in different gels. (C) Boyden chamber as-
says were performed as previously described 
to measure the impact of two independent C   
versus scrambled (SC) siRNA on hPASMC mo-
tility. Bars represent means ± SEM from n = 3.   
*,  P  <  0.01;  and  ***,  P  <  0.0001  versus 
control (CON) in A and B were determined 
using one-way ANOVA with Dunnett’s. ***, 
P < 0.0001 versus time 0; and 
##, P < 0.001 
versus scrambled siRNA in C were determined 
using one-way ANOVA with Bonferroni’s.175 BMP-2 recruits Wnt pathways in smooth muscle cells • de Jesus Perez et al.
BMP-2. Although various studies have shown that ILK-1 can 
regulate the activity of the Wnt–C pathway (Dwivedi et al., 
2008; Ho and Bendeck, 2009), evidence for a similar role in the 
regulation of the Wnt–PCP pathway is lacking. However, this 
possibility is reinforced by a previous study documenting an   
interaction between ILK-1 and Dvl in renal epithelial cells   
(Torres and Nelson, 2000). Dvl is a necessary intermediate in 
the signaling of both the canonical and noncanonical Wnt path-
ways (Boutros et al., 1998; Logan and Nusse, 2004). In fact, our 
previous work in hPAECs revealed that BMP-2 induces migra-
tion via a Dvl-dependent activation of downstream components 
of the Wnt–PCP pathway, i.e., RhoA and Rac1 (de Jesus Perez 
et al., 2009).
Interaction between ILK-1 and Dvl 
regulates hPASMC motility
The next goal of our experiments was to show that BMP-2 could 
affect Dvl distribution in hPASMCs and induce a physical inter-
action between Dvl and ILK-1, which is necessary to activate 
RhoA and Rac1 and to mediate hPASMC motility. To confirm 
that translocation of Dvl to the periphery and leading edges is 
required for BMP-2–induced hPASMC migration, cells trans-
fected with wild-type (WT) Dvl-GFP constructs were seeded in 
borosilicate sterile dual-chamber slides, and cell movement was 
followed over 10 h using time-lapse fluorescent video micros-
copy (see Materials and methods). Compared with unstimulated 
controls, BMP-2–stimulated cells formed GFP-rich lamellipodiae 
and covered a greater physical distance (Videos 1 and 2), 
whereas cells transfected with the DEP Dvl construct failed 
to respond to BMP-2 (Videos 3 and 4). Finally, to establish that 
Dvl and ILK-1 can interact in hPASMCs under BMP-2 stimula-
tion, we looked at the distribution of ILK-1 and Dvl by transfecting 
fluorophore-tagged constructs into hPASMCs. Cotransfection 
of V5-tagged WT ILK-1 and GFP-tagged Dvl constructs re-
vealed colocalization of the ILK-1 and Dvl signals when as-
sessed by confocal microscopy as early as 1 h after BMP-2 
stimulation (Fig. 6 A).
We next sought to characterize which sector of the Dvl 
structure is involved in establishing contact with ILK-1 during 
the BMP-2–mediated complex formation. It has been previ-
ously shown that Dvl-mediated activation of the Wnt–C or 
the Wnt–PCP signaling pathway is dependent on the availabil-
ity of the specific Dvl domains DIX, PDZ, and DEP (Axelrod 
et al., 1998; Boutros et al., 1998). Although DIX is mainly in-
volved in Wnt–C signaling, PDZ and DEP appear to be re-
quired in Wnt–PCP functions, with PDZ affecting RhoA and 
DEP linked to Rac1 activation (Axelrod et al., 1998; Boutros   
et al., 1998). In addition, analysis of the secondary and tertiary 
structure of the ILK-1 protein has shown that, in addition to the 
kinase domain at the C terminus, there is an ankyrin repeat do-
main (ARD) at the N terminus (Velyvis et al., 2001). The ARD is 
a common protein–protein interaction motif that allows ILK-1   
to interact with a wide variety of proteins in various cellular 
compartments  (Dobreva  et  al.,  2008),  especially  with  those 
such as PINCH-1, which are involved in cytoskeletal regulation 
and cell motility (Zhang et al., 2002; Fukuda et al., 2003). In ad-
dition, the Frizzled receptors use ARDs to regulate the activity 
41 is required for BMP-2–mediated activation of ILK-1 
and PASMC motility.
We next investigated whether ILK-1 is required for migra-
tion of hPASMCs in response to BMP-2 stimulation. To test this, 
we transfected cells with either scrambled or ILK-1 siRNA to pro-
duce a >50% knockdown in ILK-1 protein levels (Fig. S2 C) and 
studied the motility response to BMP-2 using the Boyden chamber 
assay. ILK-1–deficient hPASMCs failed to migrate in response to 
BMP-2, but the response to PDGF-BB was unchanged (Fig. 5 C). 
When levels of active RhoA and Rac1 were measured in cell ly-
sates using the pull-down assay as reported earlier in this paper, 
we also found that ILK-1–deficient cells lacked RhoA and Rac1 
activation in response to stimulation with BMP-2 (Fig. 5 D).
Collectively, these experiments support a requirement for 
ILK-1 in modulating the migratory response of hPASMCs to 
Figure 3.  BMP-2 activates C via pAkt-dependent inhibition of GSK3 
and is independent of Smad signaling. (A and B) C activation in 10 ng/ml 
BMP-2–stimulated hPASMCs transfected with a nonfunctional pAkt (Akt) 
in A and a Smad 1 construct (Smad 1) in B was measured by immunoblot 
analysis and compared with values in cells transfected with vector alone. 
The pGSK3 activation in A was measured relative to total GSK3. Bars 
represent means ± SEM from n = 3. ***, P < 0.0001 versus time 0 in A 
was determined using one-way ANOVA with Dunnett’s. ***, P < 0.0001 
in B were determined using the unpaired t test.JCB • VOLUME 192 • NUMBER 1 • 2011   176
sequence of each of our Dvl constructs showed a preservation   
of the PRS, leading us to postulate that, whereas binding to PRS   
in the context of an intact PDZ may be necessary for initial   
ILK-1–Dvl interaction, stabilization after BMP-2 stimulation re-
quires that the PRS domain be presented in a conformation that 
also involves the DEP domain.
To map the site of the Dvl–ILK-1 interaction, we used two 
previously described GFP-tagged Dvl constructs: one contain-
ing a WT form and another (DEP Dvl) containing a truncated 
of some components of the Wnt–PCP pathway (Feiguin et al., 
2001; Das et al., 2004). Analysis of Dvl mutants in Drosophila 
melanogaster revealed that mutations in the region between the 
PDZ and DEP domains (amino acids 312–362) contain a proline-
rich sequence (PRS) that could act as a putative SH3-binding 
domain and assist in protein–protein interactions (Penton et al., 
2002). Furthermore, in addition to its role as an SH3-binding 
domain, the PRS also serves as a binding platform for ARD in 
proteins such as ANKRA (Rader et al., 2000). Review of the 
Figure 4.  Production and secretion of FN is dependent on BMP-2–mediated activation of C. (A and B) Quantitative RT-PCR (A) and Western immuno-
blotting (B) were used to measure changes in levels of FN mRNA and protein, respectively, in hPASMCs stimulated with 10 ng/ml BMP-2 over a period of 
6 h. In B, levels of secreted FN were measured in hPASMCs transfected with either scrambled or two independent C siRNAs. Densitometry values were 
expressed as the ratio of OD of FN relative to the Ponceau stain of an unrelated band in media samples concentrated by ultrafiltration. Bars represent 
means ± SEM from n = 3. **, P < 0.001; and ***, P < 0.0001 versus time 0 using one-way ANOVA with Dunnett’s. (C) Representative immunofluores-
cence images showing FN distribution in scrambled (top) or C siRNA (bottom)–transfected hPASMCs stimulated with 10 ng/ml BMP-2 over 6 h. DAPI (blue) 
stain was used to label cell nuclei. Bar, 10 µm.177 BMP-2 recruits Wnt pathways in smooth muscle cells • de Jesus Perez et al.
Dvl  failed  to  form  ILK-1–Dvl  complexes  either  at  baseline   
or upon BMP-2 stimulation (Fig. 6 B). Despite their differences 
in the patterns of Dvl–ILK-1 complex formation, both DEP 
and PRS Dvl–transfected cells failed to activate RhoA-Rac1 
(Fig. 6 C) or migrate in response to BMP-2 when compared 
with cells transfected with WT Dvl (Fig. 6 D).
The presence of DEP Dvl facilitates 
proliferation in response to PDGF-BB
Besides its role in promoting RhoA and Rac1 activation, the re-
cruitment of Dvl by ILK-1 may also shuttle Dvl away from the 
Wnt–C pathway, leading to enhanced GSK3 activity and   
version lacking the DEP (i.e., Rac1 activating) domain (Axelrod 
et al., 1998; de Jesus Perez et al., 2009). In addition, we used the 
WT Dvl construct to generate a mutant containing functional 
DIX, PDZ, and DEP domains and a nonfunctional PRS (see 
Materials and methods). These constructs were then transfected 
into hPASMCs, and their ability to bind to ILK-1 was measured 
using coimmunoprecipitation (Co-IP; see Materials and methods). 
In contrast to the temporal increase in Dvl–ILK-1 complex for-
mation seen in BMP-2–stimulated hPASMCs transfected with 
WT Dvl, unstimulated cells transfected with DEP Dvl showed 
increased complex formation that fell below baseline levels   
under BMP stimulation, whereas those transfected with PRS 
Figure 5.  Activation of integrin-linked kinase 1 (ILK-1) is required for BMP-2–mediated hPASMC motility. (A) ILK-1 kinase assay was performed as de-
scribed in Materials and methods with GSK3 as the substrate on cells incubated in the presence (right) or absence (left) of 5 µg/ml CS-1. (B and C) Motility 
in hPASMCs exposed to CS-1 (B) or transfected with either scrambled (SC) or ILK-1–specific siRNA (C) and exposed to 10 ng/ml BMP-2 was measured 
using the Boyden assay. (D) Levels of active RhoA and Rac1 were measured as described in Materials and methods. Densitometry values are shown rela-
tive to total RhoA and Rac1 in whole cell lysates, which were run in different gels. Bars represent means ± SEM from n = 3. In A, *, P < 0.01; and ***,   
P < 0.0001 were determined using one-way ANOVA with Dunnett’s. In B and C, **, P < 0.001; and ***, P < 0.001 versus baseline; and 
##, P < 0.001; 
and 
###, P < 0.0001 versus respective scrambled siRNA control using one-way ANOVA with Bonferroni’s. In D, *, P < 0.01; and ***, P < 0.0001 versus 
time 0 were determined using an unpaired t test. CON, control.JCB • VOLUME 192 • NUMBER 1 • 2011   178
Figure 6.  ILK-1–dependent recruitment of Dvl is necessary for BMP-2–mediated hPASMC migration. (A) Confocal microscopy was used to localize ILK-1 
(red) and Dvl (green) in hPASMCs stimulated with 10 ng/ml BMP-2. DAPI (blue) was used to label the nuclei. Bars, 10 µm. (B) Co-IP of V5-tagged ILK-1 and 
WT, DEP, and PRS Dvl-GFP constructs under 10 ng/ml BMP-2 stimulation. Levels of V5-tagged ILK-1 were measured against levels of -tubulin in whole 179 BMP-2 recruits Wnt pathways in smooth muscle cells • de Jesus Perez et al.
Transfection of a constitutively active C 
construct promotes hPASMC motility  
and proliferation
Our study has shown that temporal regulation of C levels by 
BMP-2 is essential to prevent hPASMC proliferation. Based on 
the data provided by the aforementioned studies, we proposed 
that constitutive activation of C would increase both prolifera-
tion and motility of hPASMCs independent of BMP-2 stimula-
tion. To test this, we transfected hPASMCs with either an empty 
vector or a plasmid containing a mutated version of C (gift 
from W. J. Nelson, Stanford University, Stanford, CA) lacking 
the N-terminal phosphorylation sites (C), making it resistant 
to proteasomal degradation (see Materials and methods). We found 
that C-transfected cells had higher baseline levels of acti-
vated RhoA-Rac1 (Fig. 8 A), with an associated increase in FN 
production (Fig. 8 B) and motility (Fig. 8 C) compared with 
vector-transfected  cells.  Finally,  cell  count  studies  of  C-
transfected cells also confirmed that their proliferation is signif-
icantly higher than that of their corresponding controls (Fig. 8 D).
In conclusion, we found that a constitutive increase in C   
levels, independent of BMP-2 stimulation, can trigger an increase in 
both hPASMC motility and proliferation. This stresses the critical 
need for a functional BMP-signaling pathway to properly regulate 
C levels and preserve the balance between proliferation and motil-
ity, which is especially important in the response to vascular injury.
Transfection of DEP leads to severe 
intimal thickening in stented aortic grafts
As our experiments showed that recruitment of Dvl by ILK-1 is 
necessary to initiate BMP-mediated motility in cultured hPASMCs 
and to suppress growth factor–mediated proliferation, we inves-
tigated whether these features were also applicable to systemic 
arterial SMCs and to neointima formation in pulmonary or sys-
temic vascular disease (Willette et al., 1999). We showed that 
human aortic SMCs (AoSMCs) stimulated with BMP-2, such 
as hPASMCs, displayed an initial early rise in C followed by a 
fall below baseline levels starting at 4 h (Fig. S3 A). Consistent 
with the response in hPASMCs, hAoSMCs transfected with WT 
Dvl migrated in response to BMP-2 but not when transfected 
with DEP Dvl (Fig. S3 B).
We next investigated the impact of interfering with BMP-
mediated Wnt–PCP-induced motility and suppression of prolif-
eration in the intact animal. Because murine models of PA 
neointima formation require a long time, and not all peripheral 
arteries show the lesions (Spiekerkoetter et al., 2009), we used 
the murine aortic stent model. A segment from the abdominal 
aorta of C57BL/6J was treated with balloon dilation and inser-
tion of a metal stent to induce endovascular injury (see Materials 
and methods for details; Ali et al., 2007). Before grafting into 
the internal carotid artery, aortic segments were sonoporated to 
reduction in C levels (Logan and Nusse, 2004). This could ex-
plain the significant decrease in C below baseline levels seen 
6 h after BMP stimulation (Fig. 2 A) and could be linked to the 
reduction in PASMC proliferation documented with BMP stim-
ulation (Zhang et al., 2003; Hansmann et al., 2008). To assess 
the possibility that disrupting Wnt–PCP in hPASMCs increases 
C levels, we transfected cells with WT or DEP Dvl-GFP and 
stimulated them with 10 ng/ml BMP-2 for 6 h. We used DEP 
rather than the PRS Dvl construct because we had previously 
shown that this construct fails to bind to activated ILK-1 after 
BMP-2 stimulation. We hypothesized that suppression of Wnt–
PCP activation by DEP Dvl would result in sustained C   
protein  levels  and  transcriptional  activity  in  cells  stimulated   
with BMP-2. Indeed, we were able to show that in DEP Dvl–
transfected PASMC, both C and pGSK3 levels remained ele-
vated at 6 h after BMP-2 stimulation, whereas in cells transfected 
with WT Dvl, pGSK3 and C values were below baseline at 
that time point (Fig. 7 A, left and middle). To explain the persis-
tent elevation of C in DEP-transfected hPASMCs, we postu-
lated that the inability of Dvl to bind to ILK-1 under BMP-2 
stimulation would allow more Dvl to remain bound to GSK3, 
thereby preventing its ability to phosphorylate and target C for 
proteasomal degradation (Logan and Nusse, 2004). To test this, 
we performed Co-IP experiments in cells transfected with either 
WT  or  DEP  Dvl  and  measured  the  association  between 
pGSK3 and the two Dvl constructs over 6 h after BMP-2 stim-
ulation. Our findings demonstrate that, although pGSK3–Dvl 
complexes in WT Dvl–transfected cells appear at 1 h and fall by 
6 h, formation of the complex persists at 6 h in the DEP Dvl–
transfected hPASMCs (Fig. 7 A, right).
We then investigated whether persistent elevation in C 
activity could subvert the antiproliferative effects of BMPs in 
DEP Dvl–transfected hPASMCs when exposed to growth   
factors. To test this, we transfected cells with either WT or 
DEP Dvl and exposed them with PDGF-BB, BMP-2, or both 
for 72 h and measured changes in cell numbers. We found that 
PDGF-BB–mediated proliferation of hPASMCs was augmented   
in  DEP  Dvl  compared  with  the WT  Dvl–transfected  cells   
(Fig. 7 B). Moreover, BMP-2 suppressed the PDGF-BB–mediated 
growth response in WT Dvl but not in DEP Dvl–transfected 
hPASMCs.  Cotransfection  of  hPASMCs  with  DEP  or WT 
Dvl, along with either scrambled or two independent C-specific 
siRNA, was performed (Fig. 7 C, top and bottom). We found 
that knockdown of C reduced PDGF-BB–mediated prolifera-
tion in both WT and DEP Dvl hPASMCs and abrogated the 
enhanced growth response to PDGF-BB observed previously in 
DEP Dvl–transfected hPASMCs (Fig. 7 C, top and bottom).   
In addition, we found that BMP-2–mediated suppression of 
PDGF-BB was partially restored in hPASMCs transfected with 
DEP Dvl and two independent C siRNAs.
cell lysates analyzed in a separate gel. (C) RhoA (left) and Rac1 (right) activation in BMP-2–stimulated hPASMCs transfected with either WT, DEP, or PRS 
Dvl was performed as described in Materials and methods. Levels of active RhoA and Rac1 were measured against levels of total RhoA and Rac1 in whole 
cell lysates analyzed in a separate gel. (D) Boyden chamber assays were performed as previously described to measure the impact of WT, DEP, and PRS 
Dvl on BMP-2–induced hPASMC motility. Bars represent means ± SEM from n = 3. **, P < 0.001; and ***, P < 0.0001 versus time 0 in B and C using 
one-way ANOVA with Dunnett’s. ***, P < 0.0001 versus control (CON) unstimulated; and 
###, P < 0.0001 versus WT stimulation in D was determined 
using one-way ANOVA with Bonferroni’s. IP, immunoprecipitation. IB, immunoblot.
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using both quantitative optical coherence tomography (OCT; 
Fig. 9 A) and histomorphometry (Fig. 9 B) of vessel sections 
revealed that the neointima area was more than twofold increased 
introduce either WT or DEP Dvl-GFP constructs throughout 
the vessel wall. Transfection efficiency after sonoporation was 
confirmed via immunohistochemistry (Fig. S3 C). Our results 
Figure 7.  Presence of DEP Dvl promotes VSMC growth response to PDGF-BB by increasing C levels. (A) Levels of active C (left) and pGSK3 (middle) 
in hPASMCs transfected with either WT or DEP Dvl and stimulated with 10 ng/ml BMP-2 were visualized by Western immunoblotting and quantified 
by densitometry. Levels of active C were normalized to -tubulin, and levels of pGSK3 were normalized to total GSK3 in whole cell lysates. Co-IP of 
pGSK3 and WT and DEP (right) was carried under BMP-2 stimulation. Levels of pGSK3 were normalized relative to total GSK3 in whole cell lysates 
analyzed in a separate gel. (B) Cell count studies were performed after addition of PDGF-BB, BMP-2, or both for 72 h. (C) Cell count studies were performed 
in hPASMCs cotransfected with WT or DEP Dvl and either scrambled or two independent C siRNAs after addition of PDGF-BB, BMP-2, or both for 72 h.   
**, P < 0.001; and ***, P < 0.0001 as indicated in A were determined by one-way ANOVA with Dunnett’s. Bars represent mean ± SEM from n = 3.   
*, P < 0.01; **, P < 0.001; and ***, P < 0.0001 versus baseline; 
#, P < 0.01; and 
##, P < 0.001 versus scrambled counterpart as indicated in B and C 
using one-way ANOVA with Bonferroni’s. CON, control; IP, immunoprecipitation. IB, immunoblot.181 BMP-2 recruits Wnt pathways in smooth muscle cells • de Jesus Perez et al.
proliferation of SMCs (Fig. 10 B), thereby regulating their con-
tribution to vascular remodeling after vascular injury.
Previous work by our group has demonstrated that BMP-2 
promotes hPAEC motility by activating RhoA and Rac1 signal-
ing in a Dvl-dependent fashion, concluding that recruitment of 
Wnt–PCP is necessary for induction of cell motility (de Jesus 
Perez et al., 2009). Although our current study confirms that 
BMP-2 also regulates SMC motility through a Dvl-dependent 
Wnt–PCP pathway, the process takes longer because it requires 
C-mediated FN production. Also, BMP-2 activation of Rac1 
precedes that of RhoA, whereas they occur simultaneously in 
response to BMP-2 in hPAECs. As BMP-2–induced activation 
of RhoA and Rac1 in hPASMCs is modulated by FN-mediated 
ILK-1 binding to Dvl, it is possible that the conformational 
change in Dvl after this interaction allows preferential exposure 
of the DEP domain, thereby facilitating its earlier activation. 
Later activation of RhoA may be caused by a change in the 
composition of the protein complex, possibly from involvement 
of other binding partners that allow the PDZ domain to be prop-
erly  exposed. A  similar  pattern  of  delayed  RhoA  relative   
to Rac1 activation has been shown in neurons in response to   
netrin-1 and appears necessary to coordinate the relocalization of 
cytoskeletal and molecular elements required for axonal exten-
sion during cell growth (Picard et al., 2009). Among possible 
molecules that bind to the ILK-1–Dvl complex is the scaffold-
ing protein chloride intracellular channel 4, which we have   
previously identified as a necessary component of BMP-2– 
mediated hPASMC motility (Spiekerkoetter et al., 2009). In ad-
dition, it is interesting that we also previously reported that 
apolipoprotein (Apo) D stimulates SMC motility in a manner 
that synergizes with PDGF-BB in activating Rac1 (Leung et al., 
2004), but ApoD also suppresses PDGF-BB–mediated SMC 
proliferation by preventing nuclear translocation of pERK   
(Sarjeant et al., 2003).
In contrast to hPAECs in which BMPRII-dependent pERK 
activation is required for GSK3 inhibition, BMP-2 selectively 
recruits pAkt in hPASMCs to inactivate the GSK3–Axin–C 
degradation complex. After binding BMP-2, physical inter-
action between BMPRII and Akt may be facilitated in hPAECs 
because studies have shown these proteins are clustered within 
caveolae (Sedding et al., 2005; Wertz and Bauer, 2008). In con-
trast, in hPASMCs, BMP-2–mediated pERK is dependent not 
on BMPRII but on the receptor for end products of glycation, as 
shown previously by our group (Spiekerkoetter et al., 2009).
The pAkt-mediated C activation in hPASMCs is tran-
sient, and the fall in C is linked both temporally and function-
ally to ILK-1 binding to Dvl. This would suggest that Dvl is 
required in the Wnt–C pathway to facilitate or sustain the   
inhibition of GSK3, the main regulator of C levels in mamma-
lian cells. This model is consistent with the concept that, in 
binding Dvl, ILK-1 restores the stability of the GSK3–Axin–
C complex, which is required to target C for proteasomal 
degradation (Fig. 10 A). This mechanism would appear neces-
sary to prevent C accumulation, which, as is evident in our study, 
can derepress cell proliferation in response to growth factors. 
Conversely, the inability of mutant Dvl to bind ILK-1 may allow 
ILK-1 to inactivate its substrate GSK3 (Troussard et al., 1999), 
in DEP Dvl–treated vessels compared with WT Dvl, whereas 
the lumen area was decreased. Stent expansion was not differ-
ent between groups. None of the cross-sectional images obtained 
with OCT showed evidence of thrombi. DAPI staining of graft 
cross sections revealed that the neointima was comprised of   
many cells in DEP compared with WT Dvl–transfected vessels   
(Fig. 9 C), supporting a heightened proliferative response.
Discussion
Using isolated hPASMCs and a murine model of vascular in-
jury, we show, for the first time to our knowledge, that BMP 
signaling can induce tandem recruitment of the Wnt–C and the 
Wnt–PCP pathways to induce motility (Fig. 10 A) and suppress 
Figure  8.  Constitutively  active  C  induces  FN  production,  RhoA-Rac1, 
motility, and proliferation in hPASMCs. (A) Levels of secreted FN were mea-
sured in hPASMCs transfected with either vector or C. Densitometry   
values were expressed as the ratio of OD of FN relative to the Ponceau stain 
of an unrelated band in media samples concentrated by ultrafiltration.   
(B) RhoA (left) and Rac1 (right) activation in BMP-2–stimulated hPASMCs 
transfected with either vector or C was performed as described in Mate-
rials and methods. Levels of active RhoA and Rac1 were measured against 
levels of total RhoA and Rac1 in whole cell lysates analyzed in a separate 
gel. (C) Boyden chamber assays were performed as previously described 
in this paper to measure the impact of vector or C on hPASMC motility. 
(D) Cell count studies in hPASMCs transfected with either vector or C 
were performed for 72 h. Bars represent means ± SEM from n = 3. ***,   
P < 0.0001 versus vector using an unpaired t test.JCB • VOLUME 192 • NUMBER 1 • 2011   182
a role for FN in promoting SMC migration but not prolifera-
tion, it is possible that, in disease, excessive production and 
accumulation of FN could also enhance the response of VSMCs 
to growth factors released after injury (Nelson et al., 1997; 
Raines et al., 2000).
FN is known to interact with the 41-, 51-, and v3-
integrin complexes to promote SMC attachment, locomotion, 
and signal transduction (Jones et al., 1997; Barillari et al., 2001). 
We chose the FN CS-1 peptide to block FN–SMC interactions 
because it is more specific for FN than the RGD peptide,   
another inhibitory peptide. Also, this selects for the blockade   
of the 41-integrin complex, which is expressed on VSMCs 
(Duplàa et al., 1997; Waitkus-Edwards et al., 2002; Hsia et al., 
2005). Our results are therefore in keeping with the specificity 
of the 41 complex in activating ILK-1 in our cells.
Our study demonstrates that the VSMC motility response 
to BMP-2 is dependent on the ability of ILK-1 to form and 
maintain a stable protein complex with Dvl. Formation of an 
ILK-1–Dvl  complex  was  previously  described  in  migrating 
metanephric mesenchymal cells in which significant colocaliza-
tion of ILK-1 and Dvl in the cytoskeleton was related to forma-
tion of pseudopodia and filopodia (Torres and Nelson, 2000). 
These features are also observed with activation of the Wnt–
PCP pathway (Simons and Mlodzik, 2008; de Jesus Perez et al., 
2009). Thus, we propose that BMP-2 formation of functional 
ILK-1–Dvl complexes is required to trigger RhoA-Rac1 activa-
tion  and  coordinate  the  cytoskeletal  changes  necessary  for 
hPASMC motility (Fig. 10 A).
Our study also shows that modulation of the Wnt–PCP 
pathway by BMP signaling is common to systemic as well as 
pulmonary VSMCs. Previous studies addressing the pathobiol-
ogy of systemic vascular disease have suggested that coupling 
leading to a persistent accumulation of C (Fig. 10 B). In con-
trast to these findings in hPASMCs, the simultaneous activation 
of Wnt–C and Wnt–PCP pathways in hPAECs suggests the avail-
ability of two separate pools of Dvl.
Our study has identified BMP-2–mediated FN production 
as the bridge connecting Wnt–C with the Wnt–PCP signaling 
in hPASMCs. Although various groups have already shown that 
BMP-2 can induce production and release of FN in mesenchymal 
precursor cells and osteoblasts through recruitment of Runx2 
(Lee et al., 2000), we show, for the first time to our knowledge, 
that in SMCs, this process is regulated by C. This is in keeping 
with previous observations that link Wnt–C signaling to the 
regulation of FN production during lung development (De Langhe 
et al., 2005) as well as in diseases such as renal and pulmonary 
fibrosis (Königshoff et al., 2008; He et al., 2009).
Activation of integrin signaling by components of the ex-
tracellular matrix, such as FN, facilitates cytoskeletal reorgani-
zation before cell migration (Honda et al., 2009; Streuli and 
Akhtar, 2009; Vicente-Manzanares et al., 2009). FN regulates 
SMC migration in the ductus arteriosus, and this leads to the 
development of the intimal cushions, narrowing the ductal lumen 
and preparing the vessel for postnatal closure (Boudreau et al., 
1991). Neural crest cells migrate along an FN gradient to form 
the cardiac outflow tracts and great vessels (Henderson et al., 
2006; Eisenberg and Eisenberg, 2007). In coronary arteries   
after experimental heterotopic heart transplant, an FN gradient 
serves as a two-way highway to induce transendothelial T cell 
migration  and  to  promote  SMC  migration  in  the  neointima 
(Molossi et al., 1993, 1995). Also, after vascular injury and   
in association with PAH, accumulation of FN in the PA subendo-
thelium may promote SMC migration (Mercurius and Morla, 
1998; Morla and Mogford, 2000). Although our model supports 
Figure 9.  Transfection of DEP leads to increased neointima thickening in stented aortic grafts. Thoracic aortas from C57BL/6J mice were cannulated with 
a balloon angioplasty catheter and inflated to eight atmospheres for 30 s followed by insertion of a 2.5 × 6–mm metal stent as described in Materials and 
methods. (A) OCT cross-sectional (top) and longitudinal (bottom) images of the grafts transfected with WT (left) and DEP (right) Dvl were obtained, and 
intimal thickening was quantified. Values are expressed as percentages of the intimal area measured by comparing the cross-sectional area of the intima 
relative to the cross sectional area of the stent. The cross-sectional area of the intima is measured as the region above the white stent struts that protrude into 
the lumen. Yellow lines identify the center of the source for the infrared light in the OCT catheter. Bar, 200 µm. (B) Intimal response to balloon angioplasty 
and stenting comparing WT Dvl or DEP Dvl. Representative images of histological sections at low power from each group are shown. In both images, 
black arrowheads denote the vessel wall (endothelium to external elastic lamina), and white arrowheads show the neointima (subendothelial space to 
internal elastic lamina). Note that in the region illustrated by the arrowheads there is a very small distance between the fragmented internal elastic and the 
external elastic laminae. An unpaired t test was used to show the difference between WT and DEP Dvl; *, P < 0.05; and **, P < 0.001 (n = 5–6 mice 
per group). (C) Cross-sectional images of WT (left) and DEP (right) Dvl–transfected grafts stained with DAPI. Insets in the top images represent the areas 
illustrated on the bottom. Bar, 100 µm.183 BMP-2 recruits Wnt pathways in smooth muscle cells • de Jesus Perez et al.
can exaggerate the response, suggesting that this molecule acts 
in concert with other factors that are mediated by PDGF-BB. 
Therefore, it is possible to propose that, in the setting of vascu-
lar injury, the balance of growth (e.g., PDGF-BB) and anti-
growth (e.g., BMP) factors released from the extracellular matrix 
(Ramirez et al., 2007; Ramirez and Sakai, 2010) in the vicinity 
of VSMCs serves to translocate cells to sites of injury to reinforce 
and repair the vessel wall while preventing the excessive prolifera-
tion, which would result in pathological remodeling.
We used the aortic stent as a way of testing whether, in the 
intact animal, the exaggerated increase in C achieved with 
DEP Dvl might result in heightened proliferation in response 
to a sustained injury and, thus, worsen neointima thickening. 
We were able to optimize transfection of the medial layer by 
first physically removing the intimal layer of the aortic grafts by 
of VSMC motility and proliferation in response to growth factors 
such as PDGF-BB leads to adverse inward remodeling and the 
formation of a neointima (Fingerle et al., 1990; Reidy et al., 
1992; Majack et al., 1996). Abrogating BMP-2–mediated motility 
with the mutant Dvl did not induce proliferation despite elevated 
C levels. Rather the ability of BMP-2 to suppress PDGF-BB–
mediated proliferation was abrogated, and the PDGF-BB– 
mediated proliferative response was enhanced. Collectively, 
this suggests that elevated levels of C subvert the ability of 
BMP-2–mediated factors, such as ApoE, to inhibit PDGF-BB–
mediated proliferation (Hansmann et al., 2007, 2008).
PDGF-BB can induce C accumulation by disrupting the 
GSK3–Axin–C degradation complex via the p68 RNA heli-
case (Yang et al., 2006, 2007). Thus, suppressing C can dampen 
SMC proliferation in response to PDGF-BB, and increasing C 
Figure 10.  Proposed models for BMP regulation of hPASMC motility and proliferation by recruitment of Wnt–C and Wnt–PCP signaling. (A) BMP-2 
triggers C accumulation via pAkt-mediated GSK3 inhibition followed by production and release of FN to the extracellular space (1). By binding to 
41-integrin, FN activates ILK-1 and induces formation of a complex between ILK-1 and Dvl leading to RhoA and Rac1 activation (2) and simultaneous 
suppression of C activation (3). (B) The inability to form or maintain a complex between ILK-1 and Dvl may facilitate hPASMC proliferation in response to 
growth factors such as PDGF-BB by enhancing C signaling through ILK-1–mediated GSK3 inhibition. APC, adenomatous polyposis coli.JCB • VOLUME 192 • NUMBER 1 • 2011   184
Generation of the PRS Dvl mutant
The insert containing the full-length sequence for WT Dvl was removed from 
the pCS2 vector backbone followed by purification from an agarose gel 
using the gel extraction kit (Purelink Quick Gel Extraction; Invitrogen). The 
insert was then ligated to the pALTER-MAX vector (Promega), and its pres-
ence was confirmed by DNA sequencing. A 500-bp region encompassing 
the PRS of Dvl (found between 1,050 and 1,100 bp of the Dvl nucleic acid 
sequence) was either maintained as WT or mutagenized to convert pro-
lines to alanines (lowercase). 5-CCGCGCACGGAGCCGGTGCGACCC-
ATCGATCCCGGTGC-3 was the native sequence and 5-gCGCGCAC-
GGAGgCGGTGCGACtCATCGtTgCCGaTGC-3 was the mutant sequence. 
Site-directed mutagenesis was performed at Mutagenex Laboratories.
RNA interference
The siRNA duplexes (Thermo Fisher Scientific) specific for C (ON- 
TARGETplus; GenBank/EMBL/DDBJ accession no. NM_001012329 and 
NM_020248; and CTNNB1 ID#S438; Applied Biosystems), ILK-1 (ON-
TARGETplus; GenBank accession no. NM_001014794), and BMPRII 
(ON-TARGETplus; GenBank accession no. NM_001204) were transfected 
into  VSMCs  using  nucleofection.  Knockdown  efficiency  was  evaluated   
48 h later by measuring protein levels in lysates using a Western immuno-
blot (see Western immunoblotting).
Western immunoblotting
Samples were subjected to electrophoresis under reducing conditions and 
transferred to a polyvinylidene fluoride membrane, which was then blocked 
for 1 h in buffer (nonfat milk powder 5% in TBS/Tween 0.1%) and incu-
bated with primary antibodies overnight at 4°C. Membranes were probed 
using antibodies for active C, RhoA, and Rac1 (Millipore) and pSer 21 
GSK3 (Cell Signaling Technology). Binding of secondary HRP antibodies 
was visualized by ECL or ECL plus (GE Healthcare). A loading control was 
evaluated by reprobing the membrane with a mouse monoclonal antibody 
to -tubulin (Sigma-Aldrich).
For analysis of proteins secreted into cell media, cells were incu-
bated in phenol-free DME (Invitrogen). After stimulation, the media were 
collected and transferred to centrifugal filter devices (Amicon Ultra-4; Milli-
pore). After centrifugation, the protein concentration in the supernatant was 
measured using the Lowry assay before Western immunoblot analyses.
Densitometry of Western blots was performed via ImageJ (National 
Institutes of Health) as follows: all blots were first scanned using a photo 
scanner (Perfection 4490; Epson) at a resolution of 600 dots per inch and 
converted to TIF files. These files were then opened in ImageJ using the 
grayscale mode option available in the program. Once opened, all images 
were then inverted so that the dark parts of the film became light and the 
light parts turned dark. This was performed to increase the limit of detec-
tion of low intensity bands in the blots. Next, a rectangle was drawn 
around the highest expression band, and its mean density was measured 
using the measure function found in ImageJ. Once finished, the same rect-
angle was then used to measure all the bands within the blot. To control for 
the presence of artifacts in the blots, we drew the rectangle around the 
contours of the bands of interest and avoided including areas containing 
artifacts. Finally, the background density of the blot was measured using 
the same rectangle and subtracted from all the band measurements to give 
the net densitometry. The same procedure was then repeated with the cor-
responding loading controls.
Once the net densitometry values for experimental and loading con-
trols were obtained, a ratio of experimental/loading control was calcu-
lated. The experimental/loading optical densitometry ratios (i.e., relative 
OD) of at least three independent replicates were then used to compare 
values across different experiments. Statistical analysis was performed using 
Prism software (4.0; GraphPad Software, Inc.).
Promoter–reporter assays, plasmids, and transfection methods
For measurements of C-mediated changes in gene expression, we used 
the topflash/fopflash T cell factor/lymphoid enhancer factor reporter assay 
(Millipore). The topflash construct contains a promoter with eight T cell 
factor/LEF1–binding domains found in the promoters of C target genes 
linked to a luciferase gene, whereas the fopflash construct has mutated 
binding sites and serves as a negative control. Cells were transfected with 
2 µg of a plasmid in a transfection device (Nucleofector II Program A-033; 
Lonza) using the basic SMC Nucleofector kit (Lonza). After 24 h in starva-
tion media, cells were stimulated with agonist, and luciferase production 
was measured 6 h later in a luminometer (Turner Biosystems) using the 
Dual-Luciferase Reporter Assay kit (Promega) according to the manufac-
turer’s instructions. Renilla plasmid (Promega) cotransfection was used to 
control for transfection efficiency.
fitting a serrated catheter into the vascular lumen before sono-
poration as described in Materials and methods. A limitation of 
our in vivo study is that we were not able, for technical reasons 
involved in embedding the stent, to perform immunohistochem-
istry on the sections. Thus, we are unable to show evidence of 
heightened  C  signaling  in  the  tissue.  Moreover,  because 
PDGF-BB stimulates motility by a non-Wnt–PCP-dependent 
mechanism, we could not completely dissociate the impact of 
motility from that of proliferation in this model.
Our study suggests that the propensity to develop systemic 
or pulmonary vascular disease may lie in gene variants that 
affect the function of molecules downstream of BMP–BMPRII 
to activate the Wnt–PCP pathway. It also suggests that activat-
ing this pathway could rescue loss of BMPRII function.
Materials and methods
Cell culture
Primary hPASMCs from large vessels and AoSMCs were obtained from 
three independent commercial sources (Lonza, Invitrogen, and Sciencell), 
and all cells were found to exhibit the same biological responses to BMP-2 
stimulation. Cells were grown in SMC growth medium (5% FBS, 1 µg/ml 
hydrocortisone, 10 ng/ml of human epidermal growth factor, 3 ng/ml of 
basic fibroblast growth factor, 10 µg/ml heparin, 10 µg/ml gentamycin, 
and 0.25 µg/ml amphotericin), subcultured at a 1:4 ratio in 100-mm 
dishes (Corning), and used between passages 4 and 8. Cells were starved 
in SMC starvation medium (0.1% FBS and gentamycin/amphotericin) for 
48 h before the experiment.
Proliferation and migration assays
Cells were seeded at 25 × 10
3 cells per well on 24-well plates in SMC 
growth medium and allowed to adhere overnight. The next day, cells were 
washed and incubated in SMC starvation medium for 48 h followed by stim-
ulation with agonists for various time intervals indicated in the figure leg-
ends. Cells were then trypsinized and counted in a hemocytometer (de Jesus 
Perez et al., 2009). Migration assays were performed using the modified 
Boyden chamber assay: SMCs (10
4 cells/ml in 200 µl) were placed in the 
upper chamber in the absence or presence of 10 ng/ml BMP-2 (Sigma- 
Aldrich), 100 ng/ml Wnt3a (R&D Systems), or 20 ng/ml PDGF-BB (R&D Sys-
tems) in the lower chamber. Doses of these agonists were based on previous 
dose–response curves (Hansmann et al., 2008; de Jesus Perez et al., 2009; 
Spiekerkoetter et al., 2009). Similar responses with all three BMP ligands 
(BMP-2, BMP-4, and BMP-7) were observed in hPASMCs. In some motility 
experiments, the impact of different concentrations of the ROCK I/II–specific 
inhibitor Y-27632 (EMD) was measured against BMP-2. After 6 h of incuba-
tion, the cells were removed from the upper face of the membrane (Transwell), 
and those in the underside of the membrane were fixed and stained with 
0.5% toluidine blue in 4% paraformaldehyde. Migration was quantified with 
an inverted phase-contrast microscope (Eclipse TS100/100-F; Nikon) by 
calculating the mean number of cells in six random 200× magnification 
fields per well. The migration index was obtained by comparing the values 
in the experimental groups with the unstimulated control. All assays were 
performed in triplicate, and three separate cell harvests were assessed.
RhoA and Rac1 pull-down assays
Cells were washed three times with ice-cold PBS. Lysates were prepared by 
adding 500 µl of ice-cold magnesium lysis buffer (10 mM Tris HCl, 1.0% 
SDS, and 0.2 mM PMSF) with protease and phosphatase inhibitor cock-
tails 1 and 2 (Sigma-Aldrich) and scraping into a 1.5-ml microcentrifuge 
tube before centrifugation at 14,000 rpm for 10 min.
Active forms of RhoA or Rac1 were precipitated using glutathione 
beads containing Rhotekin or PAK1, respectively, according to the manu-
facturer’s instructions (Millipore). In brief, lysates were incubated with a 
slurry containing the glutathione beads for 1 h at 4°C with constant rota-
tion. At the end of this period, beads were precipitated by centrifuging   
lysates at 14,000 g for 20 s. After washing three times with ice-cold buffer, 
beads were resuspended in Laemmli buffer, boiled, and then subjected to 
Western immunoblot analysis as described in Western immunoblotting. 
Levels of active RhoA and Rac1 were standardized against total RhoA and 
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donor mouse to the carotid artery of a male littermate recipient. To prevent 
thrombosis, mice received 10 mg/kg/d aspirin in the drinking water, begin-
ning 1 wk before and continuing throughout the experimental period.   
In brief, all mice were anesthetized with 50 mg/kg of body weight of pento-
barbital sodium (given intraperitoneally). The thoracic aorta of the donor fe-
male mouse was isolated from the arch to the diaphragm. A small transverse 
arteriotomy was made just superior to the diaphragmatic outlet. Before intro-
duction of the stent, a serrated metal rod was introduced into the aorta   
lumen to remove the intimal layer. Next, a stainless-steel stent (Nanointerven-
tions Ltd.) 2.5 × 0.6 mm in dimension was crimped onto a 1.25 × 13–mm 
balloon angioplasty catheter (Ivatec International) and guided retrograde to 
the midportion of the descending thoracic aorta, and the balloon was in-
flated to eight atmospheres of pressure for 30 s, deploying the stent to a final 
internal diameter of 1.25 mm (balloon/vessel ratio of 1.5:1). The stented 
aorta was harvested by sealing the intercostal branch vessels with electro-
cautery. After applying a proximal ligature, the stented aorta was filled   
endoluminally with 50 µl (i.e., 5 µg) of either GFP-tagged WT Dvl or DEP 
Dvl plasmid and then sealed distally with a further ligature. The stented aortas 
containing  endoluminal  plasmid  were  sonoporated  using  a  sonoporator 
(Sonidel P100; Sonidel Limited) following the manufacturer’s instructions.
In the recipient (male) mouse, the right common carotid artery was 
isolated, ligated, and divided between ties at its midpoint. Polyethylene 
cuffs (0.65-mm diameter; Portex Ltd.) were placed over the ends of the   
vessel and anchored by microhemostatic clamps (Aesculap). Sutures at the 
ends of the artery were removed, and the artery was everted over the cuffs 
and secured with sutures. The stented aorta from the donor mouse was 
grafted by sleeving the ends of the aorta over the two ends of the carotid 
artery and ligating them. Vigorous pulsation in the conduit vessel con-
firmed successful engraftment.
Immunohistochemistry
Antigen retrieval was performed using the heat-mediated citrate buffer epi-
tope retrieval method (10 mM sodium citrate and 0.05% Tween 20, pH 6.0). 
Staining was performed using the Vectastain Elite ABC kit (Vector Labora-
tories) according to the manufacturer’s protocol. A primary rabbit anti-GFP 
antibody (Biodesign) was used to detect GFP or the plasmid distribution in 
the tissues.
OCT
OCT images were obtained with the OCT imaging system (M3; LightLab 
Imaging). ImageWire is an imaging probe that delivers the light to the   
tissue and collects the signals. The ImageWire consists of a 0.15-mm fiber-
optic core inside a sheath with a maximum OD of 0.48 mm. Motorized 
pull-back OCT imaging was performed at a rate of 1.0 mm/s. Images 
were acquired at 15 frames per second, displayed with a color look-up   
table, and digitally archived. OCT measurements were performed using 
the LightLab OCT imaging proprietary software with a mouse-based inter-
face. Lumen and stent cross-sectional areas (CSAs) were manually traced at 
1.0-mm intervals. Intimal CSA was calculated as the stent CSA subtracted 
from the lumen CSA. The percentage of intimal area was calculated as inti-
mal CSA divided by stent CSA. The mean percentage of intimal areas was 
calculated (Deuse et al., 2009).
Tissue preparation, histology, and lesion quantification
Vessels were harvested 21 d after surgery and fixed by perfusion in situ 
with 4% paraformaldehyde. Vessels were excised, fixed in paraformalde-
hyde overnight, and subsequently embedded in methyl methacrylate resin 
(Technovit 9100; TAAB Laboratories) according to the manufacturer’s in-
structions. Four transverse sections were cut through each stent using a   
diamond-coated rotary saw (IsoMet 5000; Buehler) and polished (to 5–10 µm) 
using a polisher (Metaserv 2000; Buehler).
For histomorphometric analysis, sections were stained with hema-
toxylin and eosin. Lesions were quantified for total vessel area (area inside 
the external elastic lamina), neointimal area (area inside the internal elastic 
lamina minus stent struts and minus lumen), lumen, and stent expansion 
(area inside a polygon connecting the midpoint of each stent strut). Mea-
surements of neointimal thickness were performed by measuring the per-
pendicular distance from lumen to internal elastic lamina at the midpoint 
between stent struts on each section (four to six measurements per section; 
four sections per vessel to generate n = 1). To label the nuclei, sections 
were depolymerized, and the tissue was treated with gold antifade solution 
containing DAPI and stored at 4°C until analysis.
Statistical analysis
The number of samples or animals studied per experiment is indicated in 
the  figure  legends.  Values  from  multiple  experiments  are  expressed  as 
Plasmids encoding the GFP-tagged WT and DEP form of Dvl cloned 
in pCS2 vectors were described previously (Axelrod et al., 1998). The 
plasmid containing the V5-tagged ILK-1 in a pcDNA3.1 vector was pro-
vided by S. Dedhar (University of British Columbia, Vancouver, British 
Columbia, Canada). A pcDNA 3 vector containing an Akt construct with 
a loss-of-function mutation in its active site (Akt1, K179M T308A S473A) 
was provided by W. Sellers (Dana-Farber Cancer Institute, Boston, MA).
Confocal microscopy
Cells were plated in four-chamber polystyrene glass slides (15 × 10
3 cells 
per chamber), starved for 48 h, and then stimulated with BMP-2 as specified. 
Cells were fixed in 4% paraformaldehyde and permeabilized with 0.1% 
Triton X-100 and 1% BSA in ice-cold PBS before overnight incubation with 
a primary antibody against V5 (Invitrogen) or FN (Sigma-Aldrich). The next 
day, samples were washed in PBS three times and incubated with either   
Alexa Fluor 488– or 555–tagged secondary antibodies (Invitrogen) for 1 h   
at room temperature. Before mounting, slides were treated with gold anti-
fade solution containing DAPI (Invitrogen) and stored at 4°C until analysis.
Confocal analysis was performed using a confocal laser-scanning 
microscope (SP2 AOBS; Leica) using anHCX Plan Apochromat 63× NA 
1.32–0.60 oil objective. Image acquisition was performed using the con-
focal  software  (v2.5,  build  1347;  Leica).  Images  were  processed  and 
saved in a JPEG format using Photoshop (Creative Suite 2; Adobe).
ILK-1 kinase assay
Cells were starved for 48 h before the experiment. After stimulation with 
agonist, cells were washed in PBS and lysed with ice-cold radio immuno-
precipitation assay buffer (500 µl per T75 flask). Equivalent amounts (250 µg) 
of lysates were incubated overnight at 4°C with 3–5 ml of goat polyclonal 
anti-ILK1 antibody (Abcam). The next day, the immune complexes were 
precipitated with protein G–Sepharose 4 fast-flow beads (GE Healthcare) 
and washed three times with radio immunoprecipitation assay lysis buffer 
and three times with kinase buffer (50 mM Hepes, pH 7, 2 mM MgCl2,   
2 mM MnCl2, 20 mM Na3VO4, and protease inhibitors). The kinase assay 
was performed using 2 µg GSK3 fusion protein (New England Biolabs, 
Inc.) as a substrate and 200 µM ATP in the reaction buffer (50 mM Hepes, 
pH 7, 2 mM MgCl2, 2 mM MnCl2, 20 mM Na3VO4, and 20 mM NaF) for 
30 min at 30°C. Next, Laemmli buffer was added, and samples were 
boiled for 10 min before loading onto a 4–12% Bis-Tris SDS-PAGE gel. 
Phosphorylation of the substrate was detected by Western immunoblot-
ting with anti-GSK3 Ser 21/9 antibody (Cell Signaling Technology;   
Delcommenne et al., 1998).
Digitally enhanced video differential interference contrast microscopy
48 h after transfection, cells were allowed to attach and spread on glass 
coverslips in the incubator and were then viewed using an inverted micro-
scope (Axiovert 35; Carl Zeiss, Inc.) with a Plan Apochromat 100× oil im-
mersion  lens  and  a  short-distance  condenser.  The  microscope  is  also 
equipped with heated-stage differential interference contrast optics and 
epifluorescence. Filters and lightpaths were controlled with a filterwheel 
and shutters (Ludl Electronic Products Ltd.). For GFP visualization, a single-
band excitation filter for FITC was used in combination with a beamsplitter 
and emission filter (Pinkel 1; Chroma Technology Corp.). Tissue-culture me-
dium without phenol red was kept warm and buffered in a CO2 incubator. 
The stage temperature was kept at 37°C with an automatic thermostat.   
Images were collected using a black and white charge-coupled device 
camera (C2400; Hamamatsu Photonics) with on-chip integration and a 
digital image processor (Argus 20; Hamamatsu Photonics). Acquired images 
were assembled in temporal sequences using Openlab software (PerkinElmer) 
and saved as QuickTime videos (Apple).
Co-IP
Analysis of protein–protein interactions was performed using a previously 
published protocol (Bonifacino et al., 2001). In brief, after stimulation, 
cells lysates were incubated with the immunoprecipitating antibody and 
with protein–Sepharose G beads. The samples were then subjected to 
Western immunoblot analysis.
Aortic stent graft procedure
Animal experiments were performed under a protocol approved by the   
Animal Care Committee at the Stanford University School of Medicine fol-
lowing the guidelines of the American Physiological Society. All mice were 
C57BL/6J (Jackson ImmunoResearch Laboratories, Inc.) between the ages 
of 8 and 12 wk. The operative procedure has been previously described (Ali 
et al., 2007) and involved grafting a thoracic aortic segment from a female JCB • VOLUME 192 • NUMBER 1 • 2011   186
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